The customer reported to terumo cardiovascular that during cardiopulmonary bypass, there was a circuit issue of forward flow.Perfusionist initiated hand cranking then changed the circuit.The patient was 100% responsive post surgery.There was a delay of two (2) minutes, there was a blood loss of at least 200ml, product was changed out, procedure was completed successfully.
|
This follow-up report is submitted to the fda in accord with applicable regulations - and as indicated by terumo cardiovascular system in the initial report submitted to the fda on january 27, 2017.(b)(4).The returned sample was visually inspected, during which no anomalies were noted, only dried blood could be seen within the cr filter.The reservoir sample was then set up in a circuit of bovine blood, and reservoir clotting testing was performed by circulating the blood through the cr filter for one hour.At completion of the hour, the bovine blood was flushed from the sample with saline solution and it was visually inspected.No anomalies were noted functionally during the one hour test, specifically with the flow through the reservoir.There were also no anomalies visually noted after completion of the test.A review of the device history record revealed no manufacturing anomalies.The reported event was not able to be replicated; therefore, the complaint was not confirmed and a definitive root cause was not able to be determined.Through communication with the customer contact, it is believed that the cause of the event is due to perfusionist error, and it is not believed that there are any functional issue with the terumo devices.All available information has been placed on file in quality management for appropriate tracking, trending and follow up.
|